Drug Regulatory News | China National Medical Products Administration's Drug Evaluation Center Issues the "Annual Report on the Progress of New Drug Clinical Trials in China (2025)"
2026/06/23
In order to showcase the current status of clinical trials for new drug registration in China, further enhance the transparency of clinical trials, and provide scientific reference for new drug research and approval, the Drug Evaluation Center of the National Medical Products Administration has systematically sorted out the clinical trial situation of new drug registration in China in 2025 based on the clinical trial data of the drug clinical trial registration and information disclosure platform, and compiled the "Annual Report on the Progress of Clinical Trials for New Drug Registration in China (2025)".
June 22, 2026
Original attachment: Annual Report on the Progress of Clinical Trials for New Drug Registration in China (2025)
The article is sourced from the Drug Evaluation Center of the National Medical Products Administration. The original link is:
https://www.cde.org.cn/main/news/viewInfoCommon/3c3e3f37c4b56cdd4896ef6256f5efcb
